State Street SPDR S&P Biotech ETF
769 hedge funds and large institutions have $10.2B invested in State Street SPDR S&P Biotech ETF in 2024 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 240 increasing their positions, 270 reducing their positions, and 73 closing their positions.
21% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 73
17% more funds holding in top 10
Funds holding in top 10: 18 → 21 (+3)
11% more capital invested
Capital invested by funds: $9.17B → $10.2B (+$994M)
1.23% more ownership
Funds ownership: 128.67% → 129.89% (+1.2%)
1% more funds holding
Funds holding: 761 → 769 (+8)
11% less repeat investments, than reductions
Existing positions increased: 240 | Existing positions reduced: 270
16% less call options, than puts
Call options by funds: $2.8B | Put options by funds: $3.33B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$603M |
| 2 |
Morgan Stanley
New York
|
+$158M |
| 3 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$140M |
| 4 |
D.E. Shaw & Co
New York
|
+$98.5M |
| 5 |
Goldman Sachs
New York
|
+$77.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$281M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$260M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$223M |
| 4 |
Two Sigma Advisers
New York
|
-$76.7M |
| 5 |
MMFA
Main Management Fund Advisors
San Francisco,
California
|
-$55.5M |
XBI Hedge Fund Activity: Q3 2024 in Review
769 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in State Street SPDR S&P Biotech ETF (XBI) for Q3 2024, worth a combined $10.2B — up 11% from $9.17B a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new XBI positions and 73 closed out — a net gain of 15 holders — while 240 added to existing stakes and 270 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, adding an estimated $603M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $281M sold.
- 769 institutional investors held State Street SPDR S&P Biotech ETF (XBI) as of Q3 2024, up from 761 in Q2 2024.
- Funds reported $10.2B of State Street SPDR S&P Biotech ETF stock for Q3 2024, up 11% quarter-over-quarter.
- 88 funds opened new State Street SPDR S&P Biotech ETF positions in Q3 2024 and 73 closed out, a net change of +15 holders.
- The largest State Street SPDR S&P Biotech ETF buyer in Q3 2024 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $603M added.
- The largest State Street SPDR S&P Biotech ETF seller in Q3 2024 was Avoro Capital Advisors, an estimated $281M sold.
Based on aggregated 13F filings for Q3 2024.